Global trials face uneven electronic signature expectations, making the “last mile” of consent a frequent source of complexity and compliance risk. Many organizations still default to ink on paper in practice, even as they expand digital consenting approaches.

In this webinar, IQVIA experts Sonia Fischer, MHA, MBA, and Dana Liu, MBA, will provide a practical playbook for operationalizing a country ready signature strategy, when to use qualified versus nonqualified approaches, and how to manage the flexibility versus complexity trade off in mixed modality studies without increasing risk. They will also cover what “robust eConsent” requires beyond the signature itself (e.g., authentication, audit trail integrity, and consent lifecycle workflows like amendments/reconsent) so teams can design processes that scale and stand up to inspection.